Drug factory · FDA FEI 1518957

Nostrum Laboratories, Inc.

Bryan, Ohio, United States

Matched to FDA's records by company name, because this plant's registration on the label has expired.

United States: 1

Problems found, fixed voluntarily at FDA's last inspection, Mar 13, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

12 drug inspections on record since 2010: 2 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AcetazolamideMakes it, tests it, packages it and labels it Nostrum Laboratories, Inc. 29033-030
Aspirin and Butalbital and CaffeineMakes it, tests it and labels it Nostrum Laboratories, Inc. 29033-215
Calcium CationMakes it, tests it, packages it and labels it Nostrum Laboratories, Inc. 29033-026
CarbamazepineMakes it, tests it, packages it and labels it Nostrum Laboratories, Inc. 29033-004, 29033-019, 29033-020
CarisoprodolMakes it, tests it, packages it and labels it Nostrum Laboratories, Inc. 29033-207, 29033-214
DapsoneMakes it, tests it, packages it and labels it Nostrum Laboratories, Inc. 29033-036, 29033-037
FluoxetineMakes it and tests it Nostrum Laboratories, Inc. 29033-503
MetforminMakes it, tests it, packages it and labels it Nostrum Laboratories, Inc. 29033-031, 29033-032, 29033-055 +1
PindololMakes it, tests it and packages it Nostrum Laboratories, Inc. 29033-028, 29033-029
PiroxicamMakes it, tests it, packages it and labels it Nostrum Laboratories, Inc. 29033-012, 29033-013
SucralfateMakes it, tests it, packages it and labels it Nostrum Laboratories, Inc. 29033-003
TheophyllineMakes it, tests it, packages it and labels it Brandywine Pharmaceuticals, LLC, Nostrum Laboratories, Inc. 71321-500, 71321-501, 71321-502 +6
VenlafaxineMakes it, tests it, packages it and labels it Nostrum Laboratories, Inc. 29033-045, 29033-046

FDA inspection history

EndedResultProgramProblems noted
Mar 13, 2025Problems found, fixed voluntarilyDrug Quality Assurance4
Mar 13, 2025Problems found, fixed voluntarilyDrug Quality Assurance4
Jan 11, 2018No problems foundDrug Quality Assurance—
Jan 11, 2018No problems foundDrug Quality Assurance—
Mar 15, 2016No problems foundDrug Quality Assurance—
Mar 15, 2016No problems foundDrug Quality Assurance—
Jun 28, 2013Problems found, fixed voluntarilyDrug Quality Assurance8
Jun 28, 2013Problems found, fixed voluntarilyDrug Quality Assurance8
Jul 21, 2011Problems found, fixed voluntarilyDrug Quality Assurance—
Jul 21, 2011Problems found, fixed voluntarilyDrug Quality Assurance—
Jul 16, 2010Problems found, fixed voluntarilyDrug Quality Assurance—
Jul 16, 2010Problems found, fixed voluntarilyDrug Quality Assurance—

What inspectors wrote down

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Mar 13, 2025 inspection

Jun 28, 2013 inspection